• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

GAO: FDA work­ers feared re­tal­i­a­tion for com­ing clean on po­lit­i­cal in­ter­fer­ence be­hind sci­en­tif­ic de­ci­sions

4 years ago
FDA+

Mar­ket­ingRx Matchup: What do peo­ple think about Rex­ul­ti ver­sus Trin­tel­lix de­pres­sion TV ads? It’s close.

4 years ago
Pharma
Marketing

GSK man­u­fac­tur­ing work­ers vote to strike over pay dis­pute as Walm­s­ley promis­es com­pa­ny growth

4 years ago
Pharma

In Frank Clyburn's ab­sence, Mer­ck taps sea­soned vet­er­an to run in­ter­na­tion­al Hu­man Health busi­ness

4 years ago
People
Pharma

Ther­mo Fish­er opens site in Utah as part of sin­gle-use spend­ing spree

4 years ago
Pharma
Manufacturing

New T cell im­mune re­sponse dis­cov­ery points to 'out-of-box' can­cer ther­a­py op­tions

4 years ago
Discovery
Cell/Gene Tx

No­var­tis of­fers $25M more in med­ical aid to Ukraine while sus­pend­ing sev­er­al ac­tiv­i­ties in Rus­sia

4 years ago
Pharma

Sanofi breaks ground on car­bon-neu­tral, mul­ti-vac­cine site in Sin­ga­pore

4 years ago
Pharma
Manufacturing

Supreme Court calls on top gov­ern­ment lawyer to weigh PC­SK9 patent ap­peal

4 years ago
Pharma
Law

Ogilvy Health’s new ex­ec­u­tive cre­ative di­rec­tor brings big-name con­sumer ex­pe­ri­ence to ‘less cyn­i­cal’ health ...

4 years ago
Pharma
Marketing

For­mer IQVIA em­ploy­ees push for class ac­tion law­suit, al­leg­ing mis­man­age­ment of 401(k) plan

4 years ago
Pharma
Law

Up­dat­ed: How Gilead, Re­gen­eron and Genen­tech used po­lit­i­cal con­nec­tions to hur­ry their Covid-19 drugs

4 years ago
FDA+

Arc­turus slides on PhI­II Covid-19 vac­cine da­ta, sig­ni­fy­ing the strug­gle in pro­duc­ing fol­low-up shots

4 years ago
R&D
Coronavirus

With boost­ed biode­fense work, Heat Bio ices its name in fa­vor of NightHawk

4 years ago
Pharma
Cell/Gene Tx

Biotech fraud in ski town saga winds down as ex-pres­i­dent sen­tenced to 18 months in prison

4 years ago
People

Cit­ing 's­trate­gic con­sid­er­a­tions,' Ab­b­Vie breaks off Parkin­son's deal with biotech part­ner

4 years ago
R&D

Wel­come to 'tis­sue ther­a­peu­tics’: Dave Lennon’s $110M new ven­ture will im­plant ‘hap­py cells’ that ‘sur­vive ...

4 years ago
Financing
Startups

Te­va re­ceives CRL for re­for­mu­lat­ed schiz­o­phre­nia drug de­vel­oped with French biotech

4 years ago
R&D
FDA+

Covid-19 roundup: Poland re­fus­es to pay for more vac­cine dos­es, trig­ger­ing le­gal fight; Pfiz­er, Mod­er­na face more ...

4 years ago
Coronavirus

Flag­ship-found­ed Tessera fu­els up with $300M 'to go on a re­al­ly big ad­ven­ture' in gene edit­ing

4 years ago
Financing
Startups

Al­aba­ma set­tles for $276M with McKesson, J&J and En­do over opi­oid cri­sis

4 years ago
Pharma

FTC re­quires Hik­ma to let go of steroid drug as part of $375M ac­qui­si­tion of Custopharm

4 years ago
Deals
Pharma

Un­der new CEO Joaquin Du­a­to, J&J promis­es 's­mall, medi­um and large scale' buy­outs as spin­off nears

4 years ago
Pharma

FDA warns pe­di­atric neu­rol­o­gist for fail­ing to check el­i­gi­bil­i­ty of tri­al par­tic­i­pants

4 years ago
Pharma
FDA+
First page Previous page 546547548549550551552 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times